Palindromic rheumatism is a disease characterized by the occurrence of episodes of acute pain in the joints, accompanied by swelling and limited mobility. Deformation of the joints in the course of this disease occurs against the background of periodic exacerbations and remissions, which gave it the name "palindromic". The main mechanism of the disease's development has not been fully established, but it is assumed that autoimmune processes play a significant role in the pathogenesis. Often, patients complain of sudden onset of joint pain, which can disappear as quickly as it appears, which distinguishes palindromic rheumatism from other arthritis. At the same time, external manifestations of the disease may be minimal or absent altogether, which complicates diagnosis in the early stages.
History of the disease and interesting historical facts
Palindromic rheumatism was first described in medical literature in the mid-20th century. In 1954, doctors V.K. Tretyakov and A.N. Betina presented a paper on the characteristic manifestations of this disease. Over time, palindromic rheumatism attracted the attention of various researchers due to its unusual clinical picture. An interesting fact is that this disease was long considered rare, but later epidemiological studies showed that its prevalence may be higher than previously thought. Scientific research also emphasized the importance of studying this pathology for a better understanding of the mechanisms of autoimmune diseases in general.
Epidemiology
Epidemiological data indicate that palindromic rheumatism occurs in the population with varying frequency, but on average its prevalence is from 0.5% to 2%. According to various studies, the incidence is most often recorded in young and middle-aged people, with a predominance among women. It should be noted that in recent decades there has been an increase in the number of cases of palindromic rheumatism, which can be attributed to both improved diagnostics and changes in the environmental situation. The emergence of new research methods, such as ultrasound and magnetic resonance scanning, has allowed athletes and doctors to detect this disease at an early stage.
Genetic predisposition to this disease
Research shows that palindromic rheumatism may have a genetic predisposition. Certain genes and mutations, such as those associated with the HLA (histocompatibility) system, may be involved in the pathogenesis of the disease. In particular, HLA-DR4 and HLA-DR1 are associated with an increased risk of developing this pathology. Also, genetic studies have revealed changes in genes responsible for the immune response and inflammatory processes, indicating the complex nature and multidimensional nature of this disease. It is important to note that genetic predisposition does not mean automatic development of the disease, but only increases the likelihood of its occurrence.
Risk factors for the development of this disease
Environmental disturbances, stress and lifestyle play an important role in the development of palindromic rheumatism. When considering risk factors, the following can be highlighted:
- Infectious factors such as bacterial and viral infections, which can trigger autoimmune reactions.
- Physical activity and joint injuries, which can contribute to an exacerbation of symptoms.
- Smoking, which is also associated with worsening of the condition in patients with rheumatic diseases.
- Some chemical factors, such as exposure to heavy metals and toxic substances in the body.
- Stress and psycho-emotional stress, which can affect the immune response.
Diagnosis of this disease
Diagnosis of palindromic rheumatism requires a comprehensive approach and includes several components:
- The main symptoms are sudden joint pain, swelling, and limited mobility, which may disappear within a few hours or days.
- Laboratory tests: determination of the level of inflammatory markers (C-reactive protein, ESR), as well as autoantibodies (for example, rheumatoid factor). Normal levels of indicators are often found in the absence of exacerbations.
- Radiological examinations: X-rays, which may show changes only in acute cases, while in the period of remission the X-ray may be completely normal.
- Other types of diagnostics: ultrasound of joints and MRI, which can reveal hidden changes in joint tissues that are not visible on X-rays.
- Differential diagnosis: Important to exclude other forms of arthritis such as osteoarthritis, rheumatoid arthritis and reactive arthritis.
Treatment
Treatment of palindromic rheumatism should be individualized and aimed at relieving pain, reducing inflammation and preventing exacerbations. It includes:
- General treatment: rest and limitation of physical activity during exacerbations.
- Pharmacological treatment: non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, diclofenac and selective COX-2 inhibitors.
- Surgical treatment: usually used in extremely rare cases if there are irreversible changes in the joint.
- Other types of treatment: physiotherapy, injection of glucocorticoids into the joints in severe exacerbations.
List of medications used to treat this disease
The group of drugs for the treatment of palindromic rheumatism includes:
- Ibuprofen
- diclofenac
- Naproxen
- Celecoxib
- Hydroxychloroquine
- Methotrexate (in rare cases)
Disease monitoring
Monitoring of palindromic rheumatism involves regular examinations by a rheumatologist, assessment of changes in symptoms and functional abilities. Monitoring steps may include:
- Regular assessment of inflammatory marker levels.
- Monitoring side effects from medications.
- Assessing the patient's quality of life and pain level.
- The prognosis of the disease depends on the frequency of exacerbations and their severity; in most cases, the disease does not lead to significant disability, but requires long-term observation.
- Complications are rare, but in some cases may include chronic pain or limited joint function.
Age-related features of the disease
Palindromic rheumatism can manifest itself in different age groups, but is most often detected in people aged 20 to 50 years. In elderly patients, the course of the disease may be milder, but their compensation mechanism is often reduced, which can lead to more severe pain. In childhood and adolescence, the disease is extremely rare, but if it does occur, the clinical picture may be more intense, with more frequent exacerbations. Each age requires carefully selected treatment and health monitoring to minimize the risk of complications.
Questions and Answers
- What is palindromic rheumatism? Palindromic rheumatism is a disease characterized by periodic exacerbations of joint pain that can disappear as quickly as they appear.
- What are the main causes of palindromic rheumatism? The main causes include genetic predisposition, autoimmune reactions, infections, and environmental and lifestyle factors.
- What diagnostic methods exist for palindromic rheumatism? Diagnostic methods include laboratory tests, radiological studies, ultrasound and MRI of the joints, as well as differential diagnosis with other forms of arthritis.
- How is palindromic rheumatism treated? Treatment includes pharmacological therapy with nonsteroidal anti-inflammatory drugs, physical therapy, and in rare cases, surgical intervention to correct joint deformities.
- What is the prognosis for patients with palindromic rheumatism? The prognosis is usually favorable, the disease does not lead to significant disability, but requires regular monitoring and can recur throughout life.
